Novo A/S as of Sept. 30, 2015
Portfolio Holdings for Novo A/S
Novo A/S holds 19 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 30.4 | $294M | 3.0M | 98.72 | |
| Ophthotech | 20.6 | $199M | 4.9M | 40.52 | |
| Inogen (INGN) | 17.8 | $172M | 3.5M | 48.55 | |
| Vanguard Intl Equity Index F Ftse Europe Etf (VGK) | 10.7 | $103M | 2.1M | 49.18 | |
| Nevro (NVRO) | 3.0 | $29M | 626k | 46.39 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 2.7 | $26M | 2.7M | 9.66 | |
| Wright Medical Group Contingent Value Rights (Principal) | 2.2 | $21M | 4.6M | 4.52 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.7 | $17M | 1.4M | 11.97 | |
| Otonomy | 1.6 | $16M | 875k | 17.81 | |
| Flexion Therapeutics | 1.6 | $15M | 1.0M | 14.86 | |
| Akebia Therapeutics (AKBA) | 1.5 | $15M | 1.5M | 9.66 | |
| Tokai Pharmaceuticals | 1.3 | $13M | 1.2M | 10.35 | |
| Colucid Pharmaceuticals | 1.2 | $12M | 3.1M | 3.87 | |
| Invuity | 1.1 | $11M | 787k | 14.02 | |
| Htg Molecular Diagnostics | 1.0 | $9.8M | 1.3M | 7.62 | |
| Nabriva Therapeutics | 0.9 | $8.2M | 867k | 9.50 | |
| Penumbra (PEN) | 0.4 | $4.2M | 105k | 40.10 | |
| Glaukos (GKOS) | 0.2 | $1.8M | 75k | 24.19 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.1M | 128k | 8.26 |
